“Oxybutynin and tolterodine for treatment of neurogenic detrusor overactivity: a pharmacoeconomic evaluation in the Brazilian context”, Braz. J. Pharm. Sci., vol. 48, no. 2, pp. 227–236, Jun. 2012, doi: 10.1590/S1984-82502012000200006.